Infectious Disease · Medical Literature
[World Report] Cambodia reaches HIV milestone
Abstract
Cambodia is the first country in the Asia–Pacific to reach the 95–95–95 targets. There is hope that other countries might learn from its success. Sima Barmania reports from Bangkok and Phnom Penh.
Clinical relevance
What programmatic strategies enabled Cambodia to become the first country in the Asia-Pacific region to achieve the UNAIDS 95–95–95 HIV targets, and what challenges remain on the path toward HIV elimination? __SNAPSHOT__ {"studyDesign":"World Report / Journalistic narrative report (not a primary research study or clinical trial)","setting":"Cambodia (Phnom Penh and Bangkok); national HIV program; low- and middle-income country context","sampleSize":"National program level; approximately 76,000 people living with HIV/AIDS reported by Cambodia's 2025 Ministry of Health","population":"All people living with HIV in Cambodia, with specific attention to key populations (men who have sex with men, sex workers, people who inject drugs) and their partners, who account for approximately 84% of estimated new infections","intervention":"Multisectoral, community-led national HIV response encompassing: universal ART access, multi-month ARV dispensing, HIV self-testing, long-acting PrEP (including injectable cabotegravir), peer-led counseling and adherence support, social protection linkage (IDPoor equity cards, Health Equity Fund), and integration of HIV services into the broader health system","comparator":"Not applicable (single-country descriptive/narrative report; no control group)","primaryOutcome":"Attainment of the UNAIDS 95–95–95 targets: ≥95% of PLHIV know their status; ≥95% of diagnosed PLHIV receiving ART; ≥95% of those on ART achieving viral suppression","followUp":"Long-term national program trajectory referenced; Cambodia previously achieved 90–90–90 targets in 2017 (three years ahead of schedule); current milestone declared June 2026","fundingSource":"Multi-source: Royal Government of Cambodia (domestic), UNAIDS, PEPFAR/CDC, Global Fund; sustainability concerns noted amid declining external funding"}
Key findings
Cambodia has formally achieved all three UNAIDS 95–95–95 benchmarks, becoming the first country in the Asia-Pacific region and one of only seven countries globally to do so. Specific cascade figures confirmed in corroborating sources include viral suppression exceeding 98% among those on ART, with Cambodia treating nearly 100% of people aware of their HIV-positive status. Approximately 76,000 people are living with HIV/AIDS nationally (2025 Ministry of Health estimate), with approximately 700 AIDS-related deaths recorded in 2025. Despite cascade success, new infections are not eliminated: an estimated 958 new infections occurred in 2025, of which 84% were among key populations and their partners. Since 2010, new infections have decreased by approximately 45%—described as more than three times faster than the average Asia-Pacific rate of decline (not reported with CI or p-value). Cambodia's national target is to reduce new infections to fewer than 250 cases per year by 2030. No comparative trial data, confidence intervals, p-values, NNT, or NNH are reported; this is a programmatic World Report, not a controlled study.
Practice implications
This World Report documents a landmark public health achievement: Cambodia has reached all three UNAIDS 95–95–95 HIV cascade targets, the first in its region and only the seventh country globally. The report establishes that a sustained, multisectoral, community-integrated program—encompassing universal free ART, peer-led services, social protection linkage, multi-month dispensing, and innovative prevention tools such as long-acting injectable PrEP—can achieve cascade targets even in a low- and middle-income setting. However, it does not establish causality between any single intervention and target attainment, does not provide a comparison group, and cannot be used to isolate which components were most critical. Importantly, achieving 95–95–95 does not equate to epidemic elimination: new infections are ongoing, concentrated disproportionately among key populations and youth, and HIV-related stigma and discrimination persist as barriers. Generalizability to other Asia-Pacific countries is plausible as a proof-of-concept but will depend on country-specific political will, financing, health system capacity, and the legal environment for key populations. A critical structural vulnerability is the dependence on external donor funding at a time of declining global HIV aid; the report signals this as an urgent sustainability concern. As this is a World Report rather than a peer-reviewed primary study, and only an abstract/summary was available for analysis, quantitative claims should be interpreted in that context. __LIMITATIONS__ 1. Study design: This is a journalistic World Report, not a controlled study; no hypothesis testing, no comparison group, no inferential statistics. 2. Causality cannot be established: which specific interventions drove cascade attainment is not determinable. 3. Data source opacity: underlying national surveillance data, estimation methodologies, and audit trails for the 95–95–95 cascade figures are not detailed in the report. 4. Selection and reporting bias: programmatic success stories may be preferentially highlighted, with less visibility into sub-national heterogeneity or populations missed. 5. Key population gaps: rising HIV incidence among men who have sex with men is documented by UNAIDS separately, suggesting uneven cascade performance across sub-groups. 6. Generalizability: Cambodia's political context, long-standing international partnerships (including 30 years of UNAIDS support and PEPFAR engagement), and specific social protection infrastructure may not be replicable in all regional settings. 7. Sustainability risk: the program has relied substantially on external donor funding that is now declining; long-term durability of the 95–95–95 achievement is uncertain. 8. Abstract-only limitation: the full Lancet World Report article was not available for review; additional nuance, data, and caveats from the full text may be absent from this summary. __BOTTOM_LINE_CATEGORY__ potentially_practice_informing __BOTTOM_LINE__ Cambodia's achievement of the UNAIDS 95–95–95 HIV targets—the first in the Asia-Pacific—demonstrates that cascade control is attainable in a low- and middle-income setting through sustained political commitment, community-led service delivery, universal free ART, multi-month dispensing, and innovative prevention modalities including long-acting PrEP. However, epidemic elimination remains unfinished: an estimated 958 new infections occurred in 2025, 84% concentrated among key populations, and structural threats including declining external funding and persistent stigma require urgent attention. Clinicians and public health practitioners should recognize this as a compelling programmatic proof-of-concept while acknowledging that no controlled causal data exist and that sustainability of these gains depends on rapid transition to domestic financing and continued investment in community-led services.